5-Fluoropicolinic acid | CAS:107504-08-5

We serve 5-Fluoropicolinic acid CAS:107504-08-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 5-Fluoropicolinic acid

Chemical Name:     5-Fluoropicolinic acid
CAS.NO: 107504-08-5
Synonyms:5-Fluoro-2-pyridinecarboxylic Acid;
5-fluoropyridine-2-carboxylic acid;
5-Fluoro-2-picolinic acid;
5-Fluoropicolinic Acid;
Molecular Formula: C6H4FNO2
Molecular Weight: 141.10000
 
Physical and Chemical Properties:
Density: 1.419g/cm3
Melting point: /
Boiling point: 275.1ºC at 760 mmHg
Flash point:  120.2ºC
Index of Refraction: 1.412
 
Specification:
Appearance:   White powder
Purity:≥98.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry.
Application:    used to Pharmaceutical intermediate



Contact us for information like 5-Fluoropicolinic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Fluoropicolinic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-fluoropyridine-2-carboxylic acid Use and application,5-Fluoro-2-picolinic acid technical grade,usp/ep/jp grade.


Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.3-Methoxypropylamine manufacturer What remains unknown is how exactly this nCoV came about and how easily it could spread, with researchers at Imperial College London suggesting on 20 January there could have been more than 1,700 cases in Wuhan alone by that point, when Chinese authorities were reporting just 62.5-Bromo-2-chlorobenzaldehyde supplier As many as 9,000 medical workers in Hong Kong have pledged to strike this week, a threat that alarms the territory’s officials as they are struggling to contain the coronavirus outbreak.4,4''-Dibromo-p-terphenyl vendor What’s the background?It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.